, Shanghai, November 11 (Reporter Fan Zhonghua, Tang Yanjun) "Over the past six years, the 'spillover effect' released and continuously amplified by the CIIE has turned many of our exhibits into commodities and commodities into explosive products, and Siemens Healthineers has accumulated more than 5 new products to be displayed at the Expo, especially the first products in the world or Asia, and we hope to make the first exhibition at the Expo." ”

On the 5th, the <>th China International Import Expo opened in Shanghai, Huang Yi, vice president of imaging diagnostic system of Siemens Healthineers Greater China, said in an exclusive interview with a reporter from that Siemens Healthineers has participated in the CIIE for six consecutive years, both in terms of booth area, and the first products and innovative solutions unveiled at the CIIE are improving year by year, "As a window for China to achieve a high level of opening up, the CIIE provides multinational companies with a platform to showcase the world's advanced technology" The high-quality development of China's healthcare industry has also brought many opportunities for multinational companies, including Siemens Healthineers. ”

On November 11, the 5th China International Import Expo opened, and Siemens Healthineers exhibited its "blockbuster" new products. Photo by reporter Tang Yanjun

At the CIIE, Siemens Healthineers once again brought a number of revolutionary new products, including the world's first photon counting CT, the world's first ultra-high-performance whole-body 3T magnetic resonance, and the world's first quantum spectroscopy angiography system.

Why do you pay special attention to the "first launch effect" of the Expo? Huang Yi took photonic technology CT as an example and said that it was the CIIE that allowed Siemens Healthineers to see the process of turning exhibits into commodities and commodities into explosive products again and again.

"At the 2021th CIIE in 2022, the photon counting CT technology of semiconductor detectors made its global synchronous debut; In 10, this technology entered the special review process of the Green Innovation Channel for Medical Devices of the National Medical Products Administration of China (hereinafter referred to as 'NMPA'), and at the <>th CIIE in the same year, photon counting CT completed the Asian premiere of the physical machine. In mid-October this year, it was officially approved by the NMPA for marketing in China," said Huang Yi, adding that at the <>th CIIE, Siemens Healthineers will further comprehensively demonstrate its wide range of clinical applications and scientific research achievements.

"It is on the stage of the CIIE that photonic CT has completed the process from the initial technology demonstration, to the real machine display, to clinical certification and marketing, and now, this CT has completed clinical evaluation in two hospitals in Beijing and Shanghai, and has supported these hospitals to complete some scientific research, and the research results will also be published internationally." Huang Yi said.

In addition, "for example, the ultra-high-field 7T nuclear magnetic resonance system displayed at the CIIE in the previous two years also passed the NMPA certification in 2022 and entered the clinical application of many hospitals," Huang Yi said. Second, the green innovation channel has greatly shortened the NMPA approval time, which means that advanced technologies and products are expected to empower China's clinical practice at a time very close to that of foreign countries, or even at the same time.

In Huang Yi's view, it is this "speed of the Expo" that allows Siemens Healthineers to continuously feel the vitality and potential of the Chinese market, and continue to bring "blockbuster" new products to the Expo, and the unmet needs of China's huge medical market will also benefit from this.

At the same time, he pointed out that Siemens Healthineers is not just "transplanting" the most advanced foreign equipment to the Chinese market, but also localizing and improving it in combination with the needs of the Chinese medical market in the process of introduction, so as to better serve Chinese patients. "In fact, Siemens Healthineers currently has R&D bases in Shanghai, Wuxi and Shenzhen, owns a large number of intellectual property rights, and conducts innovative R&D in 5G remote scanning and remote diagnosis, and these Chinese innovations are also benefiting the world, realizing 'China for the world'." (ENDS)